Natural history and outcome of mucinous carcinoma of the ovary

2011 ◽  
Vol 205 (5) ◽  
pp. 480.e1-480.e8 ◽  
Author(s):  
Maria B. Schiavone ◽  
Thomas J. Herzog ◽  
Sharyn N. Lewin ◽  
Israel Deutsch ◽  
Xuming Sun ◽  
...  
2010 ◽  
Vol 116 (2, Part 1) ◽  
pp. 269-273 ◽  
Author(s):  
Kathleen M. Schmeler ◽  
Xia Tao ◽  
Michael Frumovitz ◽  
Michael T. Deavers ◽  
Charlotte C. Sun ◽  
...  

1991 ◽  
Vol 248 (3) ◽  
pp. 139-143 ◽  
Author(s):  
R. J. Collins ◽  
A. Cheung ◽  
H. Y. S. Ngan ◽  
L. C. Wong ◽  
S. Y. W. Chan ◽  
...  

2017 ◽  
Vol 4 (8) ◽  
pp. 2858
Author(s):  
Gireesha Rawal ◽  
Charanjeet Ahluwalia ◽  
Amit Kumar Yadav ◽  
Indrani Dhawan

In the biliary tract, ‘mucinous’ carcinomas in which extracellular mucin constitutes more than 50% of the tumour volume, are very rare. Those tumours in which the mucinous pattern comprises of at least 90% of the tumour are called ‘pure mucinous’ carcinomas and are exceedingly rare in the gallbladder. We describe the case of a 55 years old female, who presented with the complaints of jaundice and dull aching pain in right hypochondriac region. USG abdomen was suggestive of carcinoma along with cholelithiasis, following which cholecystectomy was performed. Grossly, a large grey-white tumour was identified whose cut surface was variegated. Sections showed a tumour which was entirely composed of pools of extracellular mucin, in which clusters of tumour cells were floating. Based on morphology and immunohistochemistry, a final diagnosis of ‘pure mucinous (colloid) adenocarcinoma’ of the gallbladder was given. This case is described owing to the rarity of this neoplasm. The clinical features, natural history and prognosis of mucinous carcinoma of GB are not very well known, due to their extreme rarity. These have been discussed in this case report. Histopathological examination is vital for a decisive diagnosis of such cases. 


2017 ◽  
pp. 557-563
Author(s):  
Caroline C. Billingsley ◽  
David M. Gershenson

1989 ◽  
Vol 33 (2) ◽  
pp. 222-224
Author(s):  
R. Soeters ◽  
W. Levin ◽  
A. Tiltman ◽  
B. Block ◽  
C.M.C. Dehaeck

2016 ◽  
pp. 221-232
Author(s):  
Jubilee Brown ◽  
Michael Frumovitz

2014 ◽  
Vol 24 (Supp 3) ◽  
pp. S14-S19 ◽  
Author(s):  
Jonathan A. Ledermann ◽  
Daniela Luvero ◽  
Aaron Shafer ◽  
Dennis O’Connor ◽  
Giorgia Mangili ◽  
...  

AbstractMucinous carcinomas of the ovary can be primary or metastatic in origin. Improvements in the pathological diagnosis have increased the ability to distinguish between primary and metastatic ovarian cancers and shown that primary mucinous carcinomas are a rare subtype of ovarian cancer. Most tumors are diagnosed at an early stage, and the prognosis after surgery is good. Advanced or recurrent mucinous carcinoma of the ovary responds poorly to current cytotoxic treatments, and the prognosis is poor. Here, we review the guidelines for surgery and the results of treatment of advanced and recurrent disease. Chemotherapy with platinum and paclitaxel is currently used to treat advanced disease, but the effect of these drugs is modest, and new treatments are needed.


Sign in / Sign up

Export Citation Format

Share Document